| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.8 |